Results 151 to 160 of about 6,551 (208)

Macrophage Metabolic Reprogramming in Rheumatoid Arthritis: Pathogenic Mechanisms and Therapeutic Implications. [PDF]

Cells
Chen L, Leng S, Liu X, Zhang J, Zhao F, Hu Z, Cai X, Lin Y.   +7 more
europepmc   +1 more source

Parallel CRISPR screens reveal pathways controlling the cell surface levels of the attractant receptor FPR1. [PDF]

Commun Biol
Akdoğan E, Lundgren SM, Kamber RA, Bassik MC, Collins SR.   +4 more
europepmc   +1 more source

Development of a GRK2-inhibitory peptide

, 2017
openaire   +2 more sources

CXCR1 and CXCR2 display receptor bias for shared chemokine agonists. [PDF]

Mol Pharmacol
Jassal C, Strawn J, Walsh E, Rajarathnam K, Rajagopal S.   +4 more
europepmc   +1 more source

GRK phosphorylation drives β-arrestin-independent internalization of chemokine receptor CXCR5. [PDF]

J Biol Chem
Crecelius JM, Zhuo Y, Manz AR, Drube J, Schulz S, Hoffmann C, Marchese A.   +6 more
europepmc   +1 more source

G protein-coupled receptor-mediated platelet thrombus formation. [PDF]

Curr Opin Hematol
Zhao X, Ma P.
europepmc   +1 more source

Spinal dorsal horn IGF1 mediates the preventive effect of electroacupuncture on cisplatin-induced peripheral neuropathy via neuronal IGF1R in mice. [PDF]

Chin Med
Fu CR, Li XC, Yang YC, Chen H, Zhang RF, Chu YX, Wang YQ, Mao-Ying QL.   +7 more
europepmc   +1 more source

Dopaminergic tone inhibits spontaneous glutamate release and augments homeostatic synaptic plasticity. [PDF]

Mol Psychiatry
Uzay B, Zhang KJ, Monteggia LM, Kavalali ET.   +3 more
europepmc   +1 more source

Signaling bias of the protease-activated receptor-1 is dictated by distinct GRK5 and β-arrestin-2 determinants. [PDF]

Cell Rep
Gonzalez Ramirez ML, Orduña-Castillo LB, Bardeleben C, Qin H, Lin Y, Birch CA, Kufareva I, Trejo J.   +7 more
europepmc   +1 more source

The β1 adrenoceptor (AR) blocker metoprolol normalises βAR cascade and caveolar protein expression and restores β1AR responsiveness in failing right ventricular myocytes. [PDF]

J Mol Cell Cardiol Plus
Norman R, Stones R, Power AS, White E, Calaghan SC, Fowler ED.   +5 more
europepmc   +1 more source